Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of the novel HLA-DPA1*02:01:21 allele by sequencing-based typing. | HLA | 2023 | 36401736 | PubTator, text mining | PubMed |
Identification of the novel HLA-DPA1*01:03:43 allele resulting from an intralocus recombination involving the DPA1*04:01:01:03 and DPA1*01:03:01:27 alleles sequenced by Next Generation Sequencing (NGS). | Int J Immunogenet | 2023 | 36342183 | PubTator, text mining | PubMed |
| Identification of the novel class II allele, HLA-DPA1*01:127. | HLA | 2023 | 36334043 | PubTator, text mining | PubMed |
| PGG.MHC: toward understanding the diversity of major histocompatibility complexes in human populations. | Nucleic Acids Res | 2023 | 36321663 | PubTator, text mining | PubMed |
| The MHC Motif Atlas: a database of MHC binding specificities and ligands. | Nucleic Acids Res | 2023 | 36318236 | PubTator, text mining | PubMed |
| Interferon-Driven Immune Dysregulation in Common Variable Immunodeficiency-Associated Villous Atrophy and Norovirus Infection. | J Clin Immunol | 2023 | 36282455 | PubTator, text mining | PubMed |
| Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. | Clin Cancer Res | 2023 | 36269797 | PubTator, text mining | PubMed |
| Identification of the novel HLA-DPA1*01:03:01:64 allele in an individual from Uttar Pradesh, India. | HLA | 2023 | 36263837 | PubTator, text mining | PubMed |
| Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development. | J Cancer Res Clin Oncol | 2023 | 36239794 | PubTator, text mining | PubMed |
| Single-cell transcriptome landscape and antigen receptor dynamic during SARS-CoV-2 vaccination. | Genes Dis | 2023 | 36097543 | PubTator, text mining | PubMed |
| Identification of the novel HLA-DPA1*01:106 allele by next-generation sequencing in a Korean cord blood donor. | HLA | 2023 | 36074519 | PubTator, text mining | PubMed |
| Identification of the novel HLA-DPA1*02:82 allele in a Punjabi individual. | HLA | 2023 | 36073256 | PubTator, text mining | PubMed |
| Allelic expression imbalance in articular cartilage and subchondral bone refined genome-wide association signals in osteoarthritis. | Rheumatology (Oxford) | 2023 | 36040165 | PubTator, text mining | PubMed |
| T-cell receptor diversity in minimal change disease in the NEPTUNE study. | Pediatr Nephrol | 2023 | 35943576 | PubTator, text mining | PubMed |
| Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation. | Gene Ther | 2023 | 35931871 | PubTator, text mining | PubMed |
| Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice. | Rev Cardiovasc Med | 2022 | 36875282 | PubTator, text mining | PubMed |
| Prognostic risk analysis related to radioresistance genes in colorectal cancer. | Front Oncol | 2022 | 36741692 | PubTator, text mining | PubMed |
| Single-cell RNA-seq reveals cellular heterogeneity from deep fascia in patients with acute compartment syndrome. | Front Immunol | 2022 | 36741388 | PubTator, text mining | PubMed |
| Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma. | Front Endocrinol (Lausanne) | 2022 | 36714595 | PubTator, text mining | PubMed |
| A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma. | Front Oncol | 2022 | 36713541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=29